The disruption of TGFβ signaling is a major hit in CRC epithelial cells and host stromal cells, and we hypothesize that this term reflects best the epithelial tumors with activated WNT and MYC signaling pathways (consensus molecular subtype 2). The gene discussed is TGFB1; the disease is colorectal carcinoma.